Rachil – Depo-Provera Meningioma in Chicago, Illinois

Background

Rachil, 41, used Depo-Provera for 11 years before developing right-side facial drooping in 2022. Scans showed a tennis ball-sized meningioma eroding her skull base.

Medical and Emotional Toll

• Facial nerve graft surgery left permanent asymmetry
• Short-term memory loss prevents her working as a CPA
• $1.1 million in medical costs (2 craniotomies, cognitive rehab)

Legal and Financial Stress

• Pfizer claimed Rachel’s age (41) made tumors "expected"
• Nursing home costs for post-surgery care bankrupted her family

Injurease’s Support

• Proved 11 years of Depo-Provera use exceeded FDA-recommended duration
• Demonstrated Pfizer’s failure to update labeling after 2016 EU tumor warnings
• Won rare punitive damages for corporate misconduct

Outcome

An Illinois jury awarded $2.05 million—the largest Depo-Provera verdict to date:
✔ Future 24/7 care ($1.2M)
✔ Lost career earnings ($620K)
✔ Punitive damages ($230K)

[fluentform_modal form_id="8" btn_text="Click to Start Case Evaluation"]